Obstetrics & Gynecology, Gynecology · San Diego, CA
NPI
1356389688
Since 2006
Specialty
Obstetrics & Gynecology, Gynecology
Code 207VG0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
9339 Genesee Ave, Ste 220
San Diego, CA, 92121
Phone (858) 455-7520
Groups this clinician bills Medicare through
Medicare paid, 2024
$152K
4,309 services
Medicare patients, 2024
537
Average age 73
Drug cost, 2024
$158K
1,170 prescriptions
Company payments, 2025
$965
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wendy M Buchi was code J0897 (injection, denosumab, 1 mg), 2,941 times for 35 patients. In total Wendy M Buchi billed 4,309 services in 30 codes, and Medicare paid $152K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,941 | 35 | $20.37 | $60K |
| 99214 Office E&M - Established | Office | 392 | 389 | $93.05 | $36K |
| 77063 Mammography | Office | 210 | 210 | $27.91 | $5,861 |
| 77067 Mammography | Office | 210 | 210 | $107.19 | $23K |
| 99213 Office E&M - Established | Office | 154 | 128 | $67.72 | $10K |
| 77080 Standard X-ray | Office | 118 | 118 | $43.78 | $5,166 |
| 96372 Injection Administration | Office | 74 | 42 | $12.29 | $909 |
| 36415 Venipuncture Blood Collection | Office | 58 | 52 | $8.65 | $502 |
| 76830 Ultrasound - Abdomen and Pelvis | Office | 53 | 46 | $91.80 | $4,866 |
| 99212 Office E&M - Established | Office | 22 | 21 | $48.78 | $1,073 |
By year: 2022 $124K for 3,714 services; 2023 $128K for 3,513 services; 2024 $152K for 4,309 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 58 | 52 | $8.65 | $502 |
Medicare prescription drug claims, 2024
In 2024, the drug Wendy M Buchi prescribed most often to Medicare patients was Estradiol, with 220 prescriptions and refills. In total Wendy M Buchi wrote 1,170 Medicare prescriptions that cost $158K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 220 | 596 | 112 | $28K |
| Progesterone Progesterone, Micronized | 142 | 402 | 46 | $6,610 |
| Estradiol (Twice Weekly) Estradiol | 122 | 294 | 45 | $16K |
| Yuvafem Estradiol | 74 | 176 | 27 | $12K |
| Dotti Estradiol | 60 | 148 | 23 | $8,413 |
| Estring Estradiol | 50 | 140 | 21 | $27K |
| Levothyroxine Sodium Generic | 43 | 129 | 14 | $594 |
| Fluconazole Generic | 40 | 40 | 26 | $254 |
| Alendronate Sodium Generic | 32 | 90 | Under 11 | $373 |
| Valacyclovir Valacyclovir Hcl | 29 | 64 | 20 | $1,475 |
| Acyclovir Generic | 20 | 36 | Under 11 | $166 |
| Clobetasol Propionate Generic | 20 | 22 | 14 | $503 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 19 | 19 | 16 | $115 |
| Trazodone Hcl Generic | 19 | 47 | Under 11 | $78.7 |
| Metronidazole Generic | 16 | 19 | 11 | $636 |
Brand drugs: 233 claims; generic drugs: 937 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wendy M Buchi $965 ($965 in general payments such as food, travel and fees) from 17 companies. The largest payer was Mayne Pharma Commercial LLC with $186.
| Company | Payments | Amount |
|---|---|---|
| Mayne Pharma Commercial LLC | 13 | $186 |
| Astellas Pharma US Inc 4503.T | 6 | $169 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $61.41 |
| Meditrina | 1 | $57.75 |
| Shield Therapeutics Inc STX.L | 1 | $56.83 |
| Millicent US Inc | 3 | $54.44 |
| Pfizer Inc. PFE | 2 | $50.93 |
| Biogen, Inc. BIIB | 2 | $49.94 |
| Exact Sciences Corporation EXAS | 2 | $46.78 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $43.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.